Hey, I'm Kramer. Welcome to Mad Money. Welcome to Crane America. Other people do my make friends. Hey, I'm just trying to make you a little money. My job is not just to teach you, but to educate, entertain, too. So, call me at 1800743 CBC. Tweet me at Jim Kramer. In any given market, you need to understand the themes, what's really going on, not in the averages, but underneath. So, on a day where the Dow lost 224 points, as we shed 008%, but the NASDAQ, where the hottest stocks are, gain 35%. Let's take a m ...

How Google Cloud Is Tackling AI’s Biggest Data Unlock https://t.co/oHa3j3vm1k https://t.co/oHa3j3vm1k ...

🚨 New Video: THE BLOCKCHAIN THAT WANTS TO REPLACE THE INTERNET?⬇️https://t.co/BRACsoZFpQCan a single blockchain replace AWS, Google Cloud, and Meta—all at once? Meet @dfinity’s Internet Computer… https://t.co/rl4x8RWMhX ...

Core Insights - Lumen Technologies, Inc. reported a narrower adjusted loss of 3 cents per share for Q2 2025, compared to an expected loss of 24 cents, and a loss of 13 cents in the same quarter last year [1][8] - Total revenues for the quarter were $3.092 billion, down 5% year over year, missing the consensus estimate by 1.1%, impacted by $46 million in one-time reimbursements related to the Rural Digital Opportunity Fund [2][8] Financial Performance - Business revenues decreased by 3.4% year over year to $2.49 billion, Large Enterprises revenues fell 2% to $732 million, Mid-Market Enterprise revenues dropped 11% to $500 million, while Public Sector revenues increased by 8% to $486 million [6] - Revenues from Mass Markets declined by 12.8% year over year to $602 million, with the addition of 34,000 Quantum fiber subscribers, bringing the total to 1.2 million [9][10] - Total operating expenses rose by 18% year over year to $3.695 billion, resulting in an operating loss of $603 million compared to an operating income of $135 million in the previous year [11] Strategic Developments - Lumen secured $9 billion in PCF deals, an increase of $500 million since Q1, driven by rising AI connectivity demand from major tech companies [3] - The company anticipates $350 million in run-rate cost benefits, up from a previous target of $250 million, and expects to achieve $1 billion in run-rate cost benefits by the end of 2027 [4] - Lumen is optimistic about selling its Mass Markets' fiber-to-the-home business to AT&T for $5.75 billion, with the transaction expected to close in the first half of 2026 [4] Cash Flow and Liquidity - Lumen generated $570 million in net cash from operations, compared to $511 million in the prior year, while free cash outflow was $209 million, up from $156 million [12] - As of June 30, 2025, the company had $1.6 billion in cash and cash equivalents and $17.565 billion in long-term debt, following a significant refinancing that reduced annual interest expenses by $50 million [13] Future Outlook - For 2025, adjusted EBITDA is projected to be between $3.2 billion and $3.4 billion, with expectations to report near the high end of this range [14] - Capital expenditures are anticipated to be between $4.1 billion and $4.3 billion, while free cash flow is now expected to be between $1.2 billion and $1.4 billion, up from previous guidance [15][16]

report. Amazon is out. Mackenzie Seagalos has the numbers for us.Hi, Mac. >> Hey there, Morgan. Amazon shares moving lower about threequarters of a percent despite a beat on both the top and bottom line.You've got EPS coming in at $168 versus A$133. Revenue also a beat at 167.7% billion versus 162.09% billion. cloud AWS.This was a big number that analysts were looking for and that came in at a growth rate in Q2 of 17.5% just beating that 17.2% estimate there. We've also got a number on revenue for AWS at 30 ...

Core Insights - BigCommerce and Feedonomics have announced a strengthened partnership with Google Cloud to enhance merchant performance through advanced AI tools [1][2][3] Group 1: Partnership and Innovations - The collaboration aims to improve product discoverability and increase conversion rates for BigCommerce merchants within the Google Cloud ecosystem [2] - Key innovations include Feedonomics Surface for optimizing product data delivery to Google Merchant Center, enhancing visibility across sales channels [6] - AI-powered data enrichment features will allow merchants to automatically enhance product catalogs, improving search performance and conversion rates [6] Group 2: Benefits for Merchants - The partnership provides merchants with enterprise-grade scalability, security, and performance necessary for success in the evolving agentic commerce landscape [3] - Advanced developer tools, combining BigCommerce's Model Context Protocol with Google's Agent Development Kit, will enable the creation of intelligent, commerce-aware merchant agents [6] Group 3: Company Backgrounds - BigCommerce is a leading open SaaS ecommerce platform serving B2C and B2B businesses globally, with a diverse customer base across 150 countries [4] - Feedonomics is a prominent data management platform that supports omnichannel growth for top brands and retailers, with numerous integrations and partnerships [5]

Partnerships & Integrations - Google Cloud is integrating Self's proof-of-humanity ZKPs [1] Technology & Innovation - Self's technology powers AI adoption & Web3 innovation for human users [1] - Self and Google Cloud are ushering in the era of data privacy [1]

AI & Ethereum Development - Pond 联合 ElevenLabsDevs、Ethereum Foundation 和 Google Cloud 举办为期两周的虚拟黑客马拉松 [1] - 黑客马拉松提供高达 5 万美元的社区支持种子资金 [1] - 黑客马拉松为 AI 初创公司提供产品发布平台，潜在用户达数千人 [1] Prizes & Opportunities - 黑客马拉松提供特别合作伙伴奖品 [1]

Core Insights - Wormhole has been selected as the official multichain partner for the SCOPE Access Fund, which provides access to Hamilton Lane's Senior Credit Opportunities Fund, with Hamilton Lane managing approximately $958 billion in assets as of March 31, 2025 [1][7]. Company Overview - Wormhole is a leading interoperability platform that connects traditional finance with the internet economy, enabling seamless movement of assets across multiple blockchain networks [2][8]. - Securitize is a prominent tokenized asset platform that partners with top-tier asset managers to tokenize real-world assets, enhancing accessibility and liquidity in institutional finance [9]. Product Development - The SCOPE Access Fund is a tokenized feeder fund that has been upgraded to include on-chain capabilities such as daily NAV pricing, instant subscriptions, and on-demand redemptions across Ethereum and Optimism [3][4]. - The integration of Wormhole's multichain capabilities transforms the SCOPE Feeder Fund into an interoperable asset, facilitating unified liquidity and composable integrations for developers [4][5]. Market Trends - There is a growing trend among large asset managers to not only tokenize funds but also to seek infrastructure that allows for the free flow of assets across different blockchain networks [5][6]. - The partnership between Wormhole and Securitize aims to redefine capital movement in the internet economy, making institutional-grade credit strategies more accessible [6]. Financial Metrics - Wormhole currently manages over $3.5 billion in multichain tokenized assets under management (MTAUM), reflecting its significant role in the evolving landscape of multichain infrastructure [5]. - Hamilton Lane's asset management includes over $138 billion in discretionary assets and more than $819 billion in non-discretionary assets [7][10].

Core Insights - Recursion Pharmaceuticals (RXRX) is strategically leveraging its AI-powered drug discovery platform through high-value collaborations, positioning itself for long-term growth and sustainability [1] - The company is advancing treatments for fibrosis, neuroscience, and oncology through partnerships with major pharmaceutical companies, which also provide substantial non-dilutive funding [2][9] Collaborations and Financial Opportunities - The collaboration with Bayer could yield milestone payments up to $1.5 billion and tiered royalties, enhancing RXRX's revenue potential [2] - The agreement with Roche allows for the launch of up to 40 programs, each potentially generating over $300 million in milestones for RXRX, along with royalties [2] - Partnerships with Sanofi and Merck diversify RXRX's pipeline across oncology, immunology, and neuroinflammation, offering billions in milestone opportunities and consistent royalty streams [2] AI Infrastructure and Technological Advancements - RXRX is heavily investing in AI infrastructure, including an alliance with NVIDIA for the upgrade of its supercomputer to BioHive-2 [3] - The acquisition of Exscientia in late 2024 added over 20 programs to RXRX's portfolio, increasing its milestone opportunity to more than $20 billion [3] - Collaborations with technology leaders like Google Cloud, Helix, and Faro Health enhance RXRX's AI capabilities, accelerating drug discovery and development [4] Competitive Landscape - In the TechBio industry, competitors such as Relay Therapeutics (RLAY) and Schrödinger (SDGR) are emerging, leveraging AI-driven platforms to develop novel therapies [5] - RLAY is advancing its lead candidate RLY-2608 into a phase III study for metastatic breast cancer, while SDGR is evaluating its lead asset SGR-1505 for B-cell malignancies [5][6] Stock Performance and Valuation - Year to date, RXRX shares have declined by 22.8%, underperforming the industry and the S&P 500 [7] - RXRX is trading at a price/book value ratio of 2.27, below the industry average of 3.14 and significantly below its five-year mean of 3.56 [11] - Loss estimates for 2025 remain constant at $1.34 per share, while 2026 estimates have narrowed from $1.17 to $1.08 [13]